Cover Image
市場調查報告書

無針注射器:醫療設備的開發平台評估

Needle Free Injections - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 357852
出版日期 內容資訊 英文 64 Pages
訂單完成後即時交付
價格
Back to Top
無針注射器:醫療設備的開發平台評估 Needle Free Injections - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年05月01日 內容資訊: 英文 64 Pages
簡介

本報告提供無針注射器相關之開發中產品調查,提供您各開發階段趨勢和產品的主要開發企業,現在進行中的臨床實驗,產業的近幾年趨勢等資訊。

第1章 目錄

第2章 簡介

  • 無針注射器概要

第3章 開發中的產品

  • 無針注射器 - 開發中產品:各開發階段
  • 無針注射器 - 開發中產品:各地區 (國家)
  • 無針注射器 - 開發中產品:各法規途徑
  • 無針注射器 - 開發中產品:各核准時期 (估計)

第4章 無針注射器 - 正在開發的開發中產品:各企業

  • 無針注射器企業 - 開發中產品:各開發階段
  • 無針注射器 - 開發中產品:各開發階段

第5章 無針注射器 開發企業與產品概要

  • B. Braun Melsungen AG
  • Bioject Medical Technologies Inc.
  • Boston Scientific Corporation
  • Crossject SA
  • Enable Injections, LLC
  • Eternity Healthcare Inc.
  • EuroJet Medical Kft.
  • Glide Pharmaceutical Technologies Limited
  • Medical International Technologies (Mit Canada) Inc.
  • PharmaJet, Inc.
  • Teva Pharmaceutical Industries Limited
  • Vaxxas Pty. Ltd.

第6章 無針注射器 - 近幾年趨勢

第7章 附錄

目錄
Product Code: GDME0178EPD

GlobalData's Medical Devices sector report, "Needle Free Injections - Medical Devices Pipeline Assessment, 2016" provides an overview of Needle Free Injections currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Needle Free Injections pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Needle Free Injections under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Needle Free Injections and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Needle Free Injections under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Needle Free Injections Overview

3. Products under Development

  • 3.1. Needle Free Injections - Pipeline Products by Stage of Development
  • 3.2. Needle Free Injections - Pipeline Products by Territory
  • 3.3. Needle Free Injections - Pipeline Products by Regulatory Path
  • 3.4. Needle Free Injections - Pipeline Products by Estimated Approval Date

4. Needle Free Injections - Pipeline Products under Development by Companies

  • 4.1. Needle Free Injections Companies - Pipeline Products by Stage of Development
  • 4.2. Needle Free Injections - Pipeline Products by Stage of Development

5. Needle Free Injections Companies and Product Overview

  • 5.1. B. Braun Melsungen AG Company Overview
    • 5.1.1. B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Bioject Medical Technologies Inc. Company Overview
    • 5.2.1. Bioject Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Boston Scientific Corporation Company Overview
    • 5.3.1. Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Crossject SA Company Overview
    • 5.4.1. Crossject SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Enable Injections, LLC Company Overview
    • 5.5.1. Enable Injections, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Eternity Healthcare Inc. Company Overview
    • 5.6.1. Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. EuroJet Medical Kft. Company Overview
    • 5.7.1. EuroJet Medical Kft. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Glide Pharmaceutical Technologies Limited Company Overview
    • 5.8.1. Glide Pharmaceutical Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Medical International Technologies (Mit Canada) Inc. Company Overview
    • 5.9.1. Medical International Technologies (Mit Canada) Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. PharmaJet, Inc. Company Overview
    • 5.10.1. PharmaJet, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Teva Pharmaceutical Industries Limited Company Overview
    • 5.11.1. Teva Pharmaceutical Industries Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Vaxxas Pty. Ltd. Company Overview
    • 5.12.1. Vaxxas Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview

6. Needle Free Injections- Recent Developments

  • 6.1. Apr 19, 2016: Rodney D. Altman, MD Joins Valeritas Board of Directors
  • 6.2. Mar 21, 2016: ICU Medical Enters into Distribution Agreement with B. Braun Melsungen
  • 6.3. Mar 15, 2016: Aradigm Announces Fourth Quarter 2015 and Full Year Financial Results
  • 6.4. Mar 14, 2016: Inovio Pharma to Acquire Assets of Bioject Medical Technologies for USD5.5 Million
  • 6.5. Mar 10, 2016: Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2015 Financial Results
  • 6.6. Jan 07, 2016: Corporate Flu Clinics Offering PharmaJet Needle-Free Flu Shots
  • 6.7. Dec 09, 2015: Crossject Enters into Agreement with Xi'an Xintong Pharma
  • 6.8. Nov 16, 2015: Allmed Acquires Majority Stake in Pronefro-Produtos
  • 6.9. Nov 12, 2015: Intermountain Healthcare Enters into Agreement with Velano Vascular
  • 6.10. Nov 09, 2015: Zogenix Provides Update and Reports Third Quarter 2015 Financial Results
  • 6.11. Oct 06, 2015: Rx Safes Enters into Distribution Agreement with Mika Medical and MK Global
  • 6.12. Oct 05, 2015: Medicom receives the growth award - Borsen Gazelle 2015
  • 6.13. Sep 14, 2015: Crossject Enters into Agreement with Sayre Therapeutics
  • 6.14. Sep 09, 2015: Enable Injections Completes Its First-In-Human Wearable Injector Pilot Trial
  • 6.15. Aug 20, 2015: PharmaJet Needle-Free Injector Becomes Part of the American Pharmacists Association Educational Curriculum
  • 6.16. Aug 13, 2015: Aradigm Announces Second Quarter 2015 Financial Results
  • 6.17. Aug 10, 2015: Zogenix Provides Corporate Update and Reports Second Quarter 2015 Financial Results
  • 6.18. Jul 28, 2015: Zogenix Raises USD98.3 Million in Public Offering of Shares
  • 6.19. Jul 16, 2015: CROSSJECT confirms the development plan for ZENEO Sumatriptan
  • 6.20. Jul 06, 2015: Zogenix Expands Senior Leadership Team to Further Drive Strategic Focus on CNS Disorders and Orphan Drug Development
  • 6.21. Jun 22, 2015: Biocorp Production Raises USD9.8 Million in IPO
  • 6.22. Jun 22, 2015: Owen Mumford Expands Global Foot Print to Support Asia Pacific
  • 6.23. May 11, 2015: Aradigm Announces First Quarter 2015 Financial Results
  • 6.24. May 11, 2015: Zogenix Provides Corporate Update and Reports First Quarter 2015 Financial Results

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Needle Free Injections - Pipeline Products by Stage of Development
  • Table 2: Needle Free Injections - Pipeline Products by Territory
  • Table 3: Needle Free Injections - Pipeline Products by Regulatory Path
  • Table 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
  • Table 5: Needle Free Injections Companies - Pipeline Products by Stage of Development
  • Table 6: Needle Free Injections - Pipeline Products by Stage of Development
  • Table 7: B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: Needle-Free System - Product Status
  • Table 9: Needle-Free System - Product Description
  • Table 10: Bioject Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: Iject R Pre-Filled Syringe - Product Status
  • Table 12: Iject R Pre-Filled Syringe - Product Description
  • Table 13: Intradermal Pen Injector - Product Status
  • Table 14: Intradermal Pen Injector - Product Description
  • Table 15: Intradermal Syringe - Product Status
  • Table 16: Intradermal Syringe - Product Description
  • Table 17: Mega Jet - Product Status
  • Table 18: Mega Jet - Product Description
  • Table 19: Multi-Port Orifices - Product Status
  • Table 20: Multi-Port Orifices - Product Description
  • Table 21: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: JetTouch System - Overactive Bladder - Product Status
  • Table 23: JetTouch System - Overactive Bladder - Product Description
  • Table 24: Crossject SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Zeneo ID Human Needle-Free Injection Device - Product Status
  • Table 26: Zeneo ID Human Needle-Free Injection Device - Product Description
  • Table 27: Zeneo IM 0.5ml Needle - Free Injection Device - Product Status
  • Table 28: Zeneo IM 0.5ml Needle - Free Injection Device - Product Description
  • Table 29: Zeneo SC 0.5ml Needle-Free Injection Device - Product Status
  • Table 30: Zeneo SC 0.5ml Needle-Free Injection Device - Product Description
  • Table 31: Zeneo SC 0.8ml Needle-Free Injection Device - Product Status
  • Table 32: Zeneo SC 0.8ml Needle-Free Injection Device - Product Description
  • Table 33: Zeneo SC High Viscosity Needle-Free Injection Device - Product Status
  • Table 34: Zeneo SC High Viscosity Needle-Free Injection Device - Product Description
  • Table 35: Enable Injections, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Wearable Enable Injector - Product Status
  • Table 37: Wearable Enable Injector - Product Description
  • Table 38: Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Multi Channel Needle-Free Injection Device - Product Status
  • Table 40: Multi Channel Needle-Free Injection Device - Product Description
  • Table 41: EuroJet Medical Kft. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Third Generation E-Jet 500 Needle Free Injector - Product Status
  • Table 43: Third Generation E-Jet 500 Needle Free Injector - Product Description
  • Table 44: Glide Pharmaceutical Technologies Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Glide SDI - Product Status
  • Table 46: Glide SDI - Product Description
  • Table 47: Medical International Technologies (Mit Canada) Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: MED-JET MBX Injector - Product Status
  • Table 49: MED-JET MBX Injector - Product Description
  • Table 50: MIT-H-III - Product Status
  • Table 51: MIT-H-III - Product Description
  • Table 52: MIT-H-IV-1 - Product Status
  • Table 53: MIT-H-IV-1 - Product Description
  • Table 54: MIT-H-IV-5 - Product Status
  • Table 55: MIT-H-IV-5 - Product Description
  • Table 56: MIT-H-VI Dental Injector - Product Status
  • Table 57: MIT-H-VI Dental Injector - Product Description
  • Table 58: PharmaJet, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Variable Volume Drug Delivery Device - Product Status
  • Table 60: Variable Volume Drug Delivery Device - Product Description
  • Table 61: Teva Pharmaceutical Industries Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: MicroDose Needlefree System - Product Status
  • Table 63: MicroDose Needlefree System - Product Description
  • Table 64: Vaxxas Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Nanopatch - Product Status
  • Table 66: Nanopatch - Product Description
  • Table 67: Glossary

List of Figures

  • Figure 1: Needle Free Injections - Pipeline Products by Stage of Development
  • Figure 2: Needle Free Injections - Pipeline Products by Territory
  • Figure 3: Needle Free Injections - Pipeline Products by Regulatory Path
  • Figure 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
Back to Top